Overview
A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-077)(COMPLETED)
Status:
Completed
Completed
Trial end date:
2005-02-01
2005-02-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to compare the safety and effectiveness of an investigational drug and an approved drug in the treatment of osteoarthritis of the knee and hip.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Merck Sharp & Dohme Corp.Treatments:
Celecoxib
Etoricoxib
Criteria
Inclusion Criteria:- Osteoarthritis of the knee or hip which requires treatment with medication for pain
relief
Exclusion Criteria:
- Any known allergies to the study drugs